塔利多米德作为艾滋病毒 - 结核病相关免疫重建炎症综合征的辅助疗法:一个案例系列
S Lee-Jones1, K Rebe2, S Marais3
1Department of Medicine, Division of Infectious Diseases, Stellenbosch University, Cape Town, South Africa.
Open forum infectious diseases
|November 3, 2025
概括
当皮质类固醇失败时,thalidomide有效地治疗了成年人复杂的HIV相关结核病-IRIS. 这种免疫调节的选择在一小群患者中显示出有利的结果,没有不良影响.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 艾滋病毒/艾滋病研究研究
背景情况:
- 一部分患有结核病相关免疫复合炎症综合征 (TB-IRIS) 的艾滋病毒患者经历了严重的,长期的疾病.
- 在这些复杂的TB-IRIS病例中,皮质类固醇治疗往往是无效的或耐受性差,需要替代治疗.
研究的目的:
- 评估thalidomide的疗效和安全性,作为艾滋病毒相关复杂结核病-IRIS的成年患者的替代免疫调节治疗.
主要方法:
- 一系列病例描述了7名患有复杂艾滋病毒相关结核病IRIS的成年患者.
- 患者接受了每天100毫克的thalidomide剂量,持续6至12个月.
主要成果:
- 这7名患者呈现出各种表现,包括中枢神经系统结核病,结核腺炎和复发性结核性psoas收集.
- 所有接受thalidomide治疗的患者都经历了良好的临床结果.
- 在治疗期间没有报告任何不良反应.
结论:
- 沙利多米德 (100 mg/天) 是一种临床上有用的药物,用于特定组的成年患者,患有复杂的与艾滋病毒相关的结核病-IRIS.
- 需要进一步的研究,以确定这种人群中thalidomide治疗的最佳剂量和持续时间.
相关概念视频
Pulmonary Tuberculosis I
817
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
817
Therapeutic Drug Monitoring: Affecting Factors
193
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
193
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
475
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
475


